STOCK TITAN

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) will showcase its MauriceFlex™ System at the 72nd ASMS Conference on Mass Spectrometry from June 2-6, 2024, in Anaheim, California.

The MauriceFlex System offers advanced imaged capillary isoelectric focusing (icIEF) solutions, including fractionation, and supports various mass spectrometric methods for protein characterization.

Highlights include a breakfast seminar on June 4th featuring Dr. Chris Heger and Dr. Sara Carillo discussing the system's applications, particularly in protein charge heterogeneity and cell and gene therapy.

Bio-Techne will also present seven posters detailing collaborations with industry leaders like Pfizer and 908 Devices, showcasing advancements in charge isoform characterization.

Will Geist, President of Protein Sciences, emphasized the system's unique capabilities and collaborative efforts at ASMS to advance life-saving therapies.

Visit Bio-Techne at Booth #161 and learn more at bio-techne.com/mauriceflex.

Positive
  • Showcasing MauriceFlex System's advanced icIEF solutions at a major industry conference could boost visibility and credibility.
  • Presentation of seven posters and a seminar indicates strong engagement with the scientific community, potentially leading to collaborations.
  • Collaborations with industry leaders like Pfizer and 908 Devices enhance Bio-Techne's reputation and could drive future business opportunities.
  • Unique icIEF fractionation capability combined with mass spectrometry can lead to novel protein characterization approaches, beneficial for developing therapies.
  • Highlighting applications in cell and gene therapy sectors could attract interest from high-growth markets.
Negative
  • No specific financial or sales data provided, making it unclear how much revenue the MauriceFlex System might generate.
  • Potential high competition in the protein characterization market from other established players.
  • The success of the MauriceFlex System relies heavily on industry adoption and the success of collaborations, which carry inherent risks.

MINNEAPOLIS, May 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) will showcase multiple applications of its recently launched MauriceFlex™ System at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics, taking place June 2nd-6th in Anaheim, California. The MauriceFlex system is Bio-Techne's latest imaged capillary isoelectric focusing (icIEF) solution, which enables icIEF-based fractionation in addition to routine icIEF and capillary electrophoresis-sodium dodecyl sulfate (CE-SDS) assays. By simplifying charge variant fraction collection, the MauriceFlex system powers flexible downstream protein characterization with various mass spectrometric (MS) methods. At ASMS, Bio-Techne will feature a breakfast seminar and several poster presentations to highlight its innovations in biomolecular characterization.

The breakfast seminar titled "Solving the Challenges of Protein Charge Heterogeneity Characterization using icIEF," will take place on June 4th in Room 213A of the Anaheim Convention Center. During this session, Dr. Chris Heger from Bio-Techne and  Dr. Sara Carillo from the National Institute for Bioprocessing Research and Training will provide insights into applications of the MauriceFlex system, including its unique ability to fractionate charge isoforms in monoclonal antibodies, followed by downstream characterization on various MS systems. The seminar will also highlight the fractionation of AAV capsid proteins, demonstrating the MauriceFlex system's suitability in cell and gene therapy applications.

In addition to the seminar, Bio-Techne will present seven posters, featuring collaborations with key industry partners including Pfizer, 908 Devices, and more. These posters will detail advances in charge isoform characterization of a variety of molecules including AAVs and bispecific antibodies, showcasing charge isoform fractionation followed by downstream characterization methods such as CZE-MS, CD-MS, and LC-MS.

"Adding icIEF fractionation capability in the MauriceFlex system enables our customers to combine icIEF with mass spectrometry analysis, leading to a novel protein characterization approach. The power of this unique capability is illustrated through a number of collaborations highlighted at this year's ASMS conference," said Will Geist, President of the Protein Sciences Segment, Bio-Techne. "We are excited to engage scientists with our seminar and posters and demonstrate our leadership in protein characterization, so that they have all the tools needed to create life-saving therapies for patients around the world."

Visit Bio-Techne at Booth #161 at ASMS! To learn more about the MauriceFlex system, visit bio-techne.com/mauriceflex.

About Bio-Techne 
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit http://www.bio-techne.com or follow the Company on social media at Facebook, LinkedIn, Twitter or YouTube.

About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-highlight-multiple-applications-of-the-mauriceflex-system-at-the-annual-asms-conference-302154694.html

SOURCE Bio-Techne Corporation

FAQ

What is Bio-Techne's MauriceFlex™ System?

The MauriceFlex™ System is an advanced imaged capillary isoelectric focusing (icIEF) solution that enables icIEF-based fractionation, routine icIEF, and CE-SDS assays, supporting various mass spectrometric methods for protein characterization.

When and where will Bio-Techne showcase the MauriceFlex™ System?

Bio-Techne will showcase the MauriceFlex™ System at the 72nd ASMS Conference on Mass Spectrometry from June 2-6, 2024, in Anaheim, California.

What are the key features of the MauriceFlex™ System?

The MauriceFlex™ System offers icIEF-based fractionation, routine icIEF, and CE-SDS assays, enabling flexible downstream protein characterization with various mass spectrometric methods.

Who are the key speakers at Bio-Techne's seminar on the MauriceFlex™ System?

Dr. Chris Heger from Bio-Techne and Dr. Sara Carillo from the National Institute for Bioprocessing Research and Training will be the key speakers at the seminar.

What kind of collaborations will Bio-Techne present at ASMS?

Bio-Techne will present collaborations with key industry partners, including Pfizer and 908 Devices, detailing advances in charge isoform characterization of various molecules.

What is the focus of Bio-Techne's seminar at the ASMS conference?

The seminar will focus on solving challenges of protein charge heterogeneity characterization using icIEF and will highlight applications of the MauriceFlex system in cell and gene therapy.

Where can I find more information about the MauriceFlex™ System?

More information about the MauriceFlex™ System can be found at bio-techne.com/mauriceflex.

Bio-Techne Corporation

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

12.58B
157.59M
0.97%
102.11%
3.44%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
MINNEAPOLIS